...A 2018 study from BMJ Global Health estimates the cost to produce a vial of insulin from between $2 for regular human insulin to less than $7 for newer analogs, like the Lispro analog Eli Lily produces. The list price for that analog is $274.70 per 10 mL vial...{snip}...The RAND Corporation 2018 study demonstrated that the cost of insulin to diabetics in the U.S. is generally five to 10 times higher than in the other OECD countries (Organization for Economic Co-operation and Development). Where the 2018 average price per vial was less than $10 for other OECD patients, it was just under $100 for U.S. patients...
“It probably highlights that we have more work to do to bring down the cost of insulin for more people...{snip}...We’ve done tons of things, but it obviously hasn’t penetrated the clutter. We’re obviously not the only insulin company. But the tropes go on."
Tons of things?
...On January 23, 1923, an American patent on both insulin and Toronto’s method of making it was awarded to Banting, Collip, and Best. For $1.00 to each, the three discoverers assigned their patent rights to the Board of Governors of the University of Toronto. The application had stressed that none of the other researchers in the past had been able to produce a nontoxic antidiabetic extract. A patent was necessary to restrict manufacture of insulin to reputable pharmaceutical houses who could guarantee the purity and potency of their products...
.